Disposition of 4559 shares by Andrew Dahl of Edwards Lifesciences at 87.62 subject to Rule 16b-3

ZIVOWDelisted Stock  USD 0.55  0.07  14.58%   
Slightly above 55% of Zivo Bioscience's sophisticated investors are presently thinking to get in. The analysis of overall sentiment of trading Zivo Bioscience Warrants stock suggests that some investors are interested at this time. Zivo Bioscience's investing sentiment can be driven by a variety of factors including economic data, Zivo Bioscience's earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by Edwards Lifesciences Corp Officer: Svp, Princ. Accounting Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Read at macroaxis.com
Disposition of 4559 employee stock option (right to acquire) at 87.62 of Edwards Lifesciences by Andrew Dahl on 13th of October 2024. This event was filed by Edwards Lifesciences Corp with SEC on 2025-02-22. Initial filing of beneficial ownership - SEC Form 3

Zivo Bioscience Fundamental Analysis

We analyze Zivo Bioscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zivo Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zivo Bioscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Return On Asset

Return On Asset Comparative Analysis

Zivo Bioscience is currently under evaluation in return on asset category among its peers. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Zivo Bioscience Warrants Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Zivo Bioscience stock to make a market-neutral strategy. Peer analysis of Zivo Bioscience could also be used in its relative valuation, which is a method of valuing Zivo Bioscience by comparing valuation metrics with similar companies.
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Consideration for investing in Zivo Stock

If you are still planning to invest in Zivo Bioscience Warrants check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zivo Bioscience's history and understand the potential risks before investing.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets